Saba, N. F., Attwood, K., Holsinger, F. C., Chinn, S. B., Henson, C., Dunn, L., Newpower, M., Jordan, R., Schmitt, N. C., Yom, S. S. (2026). NRG-HN015: A phase II randomized trial of neoadjuvant chemotherapy or chemo-immunotherapy in patients with recurrent/persistent PD-L1–positive squamous cell carcinoma of the head and neck undergoing salvage surgery.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps6128